Dow Down 0.36% Nasdaq Down 0.53%

Myriad Genetics Inc. (MYGN)

-NasdaqGS
36.53 Down 0.04(0.11%) Sep 12, 4:00PM EDT
|After Hours : 36.53 0.00 (0.00%) Sep 12, 4:26PM EDT
Prev Close:36.57
Open:36.23
Bid:N/A
Ask:45.00 x 300
1y Target Est:39.08
Beta:0.93
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:36.01 - 36.71
52wk Range:20.02 - 42.50
Volume:379,411
Avg Vol (3m):822,289
Market Cap:2.66B
P/E (ttm):15.49
EPS (ttm):2.36
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
MYGNDown 0.11%2.66B
ABTDown 0.02%63.98B

Key Statistics

Forward P/E (1 yr):16.45
P/S (ttm):3.42
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-15) :1.93
Quarterly EPS Est (Sep-14) :0.41
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):1.22

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Myriad Genetics, Inc., a molecular diagnostic company, focuses on the development and marketing of predictive medicine, personalized medicine, and prognostic medicine tests in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback